Insight

Ilya Tsimafeyeu: Intrapleural nivolumab in cancer patients with pleural effusion

Photo of Ilya Tsimafeyeu

Jul 23, 2024, 10:09

Ilya Tsimafeyeu: Intrapleural nivolumab in cancer patients with pleural effusion

Ilya Tsimafeyeu, Director at the Bureau of Cancer Research, shared on Facebook about a recent paper titled “Intrapleural nivolumab in cancer patients with pleural effusion” published in the Journal of Cancer Research and Therapeutics.

Authors: Tsimafeyeu Ilya, Goutnik Vadim, Shrainer Igor, Kosyrev Vladislav, Bondarenko Anastasia, Utyashev Igor

Ilya Tsimafeyeu

“We tried to use intrapleural nivolumab in cancer patients with pleural effusion, but unfortunately, it did not yield the desired results.

How do you treat recurrent, resistant pleural effusions in your practice?”

Source: Ilya Tsimafeyeu/Facebook

Bondarenko Anastasia cancer Goutnik Vadim Ilya Tsimafeyeu Journal of Cancer Research and Therapeutics Kosyrev Vladislav nivolumab OncoDaily Oncology pleural effusion Shrainer Igor Tsimafeyeu Ilya Utyashev Igor

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage